Xiangdong Wang

Xiangdong Wang


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2022 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
Chengshuo WangChengshuo Wang
Chengshuo Wang
YBYixiao Bao
Yixiao Bao
JCJianjun Chen
Jianjun Chen
XCXiaoyang Chen
Xiaoyang Chen
LClei Cheng
lei Cheng
C(Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G)
Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G)
Wang C, et al. Allergy Asthma Immunol Res. 2022 Nov;14(6):604-652. https://doi.org/10.4168/aair.2022.14.6.604

1 January 2020 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
ZLZheng Liu
Zheng Liu
JCJianjun Chen
Jianjun Chen
LClei Cheng
lei Cheng
HLHuabin Li
Huabin Li
SLShixi Liu
Shixi Liu
LZLuo Zhang
Luo Zhang
The current document is based on a consensus reached by a panel of experts from the Chinese Society of Allergy and the Chinese Society of Otorhinolaryngology-Head and Neck Surgery, Rhinology Group. Chronic rhinosinusitis (CRS) affects approximately 8% of Chinese adults. The inflammatory and remodeling mechanisms of CRS in the Chinese population differ from those observed in the populations of European descent. Recently, precision medicine has been used to treat inflammation by targeting key biomarkers that are involved in the process. However, there are no CRS guidelines or a consensus available from China that can be shared with the international academia. The guidelines presented in this paper cover the epidemiology, economic burden, genetics and epigenetics, mechanisms, phenotypes and endotypes, diagnosis and differential diagnosis, management, and the current status of CRS in China. These guidelines-with a focus on China-will improve the abilities of clinical and medical staff during the treatment of CRS. Additionally, they will help international agencies in improving the verification of CRS endotypes, mapping of eosinophilic shifts, the identification of suitable biomarkers for endotyping, and predicting responses to therapies. In conclusion, these guidelines will help select therapies, such as pharmacotherapy, surgical approaches and innovative biotherapeutics, which are tailored to each of the individual CRS endotypes.

1 December 2023 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
XXXiran Xie
Xiran Xie
LXLijia Xuan
Lijia Xuan
YZYajuan Zhao
Yajuan Zhao
XWXiangdong Wang
Xiangdong Wang
LZLuo Zhang
Luo Zhang

1 November 2019 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
MWMin Wang
Min Wang
NZNan Zhang
Nan Zhang
MZMing Zheng
Ming Zheng
YLYing Li
Ying Li
LMLingling Meng
Lingling Meng
CBClaus Bachert
Claus Bachert
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous disease with a spectrum of endotypes. TH2- and TH17-related cytokines are 2 central regulators involved in the inflammation associated with CRSwNP. We sought to investigate the interregulation of TH2 and TH17 pathways in Chinese patients with CRSwNP. Levels of key TH2- and TH17-related factors were measured in homogenates of polyp tissue obtained from patients with CRSwNP. The relationship of these factors and their expression in groups classified according to tissue IL-5 and IL-17 concentrations were analyzed. Cross-regulation of TH2 and TH17 cytokines and the effects of dexamethasone treatment were studied in dispersed nasal polyp cells. Associations between TH2- and TH17 related factors and comorbid atopic status and asthma, disease recurrence, and edema scores were also explored. Four CRSwNP groups were classified based on expression or nonexpression of mutually exclusive TH2- and TH17-related factors. The TH2 cytokines IL-4 and IL-13 inhibited expression of TH17-related factors, whereas the TH17 cytokines IL-17 and TGF-β1 enhanced expression of TH2-related factors. Dexamethasone treatment inhibited both the TH2 and TH17 pathways. A patient's atopic status was related to their TH2 immune response. Edema scores were positively correlated with the TH2 pathway and negatively correlated with the TH17 pathway. The TH2 and TH17 pathways are mutually exclusive and regulate each other, favoring the development of a TH2 immune response in Chinese patients with CRSwNP.

4 November 2021 in Allergy
Verified
Journal Article
Closed access
PDF file
YZYan Zhao
Yan Zhao
JCJunru Chen
Junru Chen
YHYun Hao
Yun Hao
BWBoqian Wang
Boqian Wang
YWYue Wang
Yue Wang
LZLuo Zhang
Luo Zhang

6 September 2021 in Clinical and Translational Allergy
Verified
Journal Article
Open access
PDF file
KDKun Du
Kun Du
MWMin Wang
Min Wang
NZNan Zhang
Nan Zhang
PYPei Yu
Pei Yu
PWPing Wang
Ping Wang
CBClaus Bachert
Claus Bachert
Background: Tissue remodeling caused by increased MMPs is involved in the pathogenesis of chronic rhinosinusitis with nasal polyposis (CRSwNP). We previously found higher levels of periostin and tenascin C in CRSwNPs, but whether they are associated with the dysregulation of MMPs is unknown. Therefore, the present study aimed to investigate the regulatory roles of these two ECM proteins in the expression of MMPs in nasal polyps.Methods: The concentrations of MMP‐2, MMP‐3, MMP‐7, MMP‐8, MMP‐9, MMP‐12, MMP‐13, TIMP‐1, TIMP‐2, TIMP‐3, TIMP‐4, periostin, and tenascin C in tissue homogenates of 51 patients with chronic rhinosinusitis with and without nasal polyps and 15 control subjects were measured and were analyzed by adjusted logistic regression and spearman correlation test. Primary human nasal polyp fibroblasts and epithelial cells were stimulated ex vivo with periostin and tenascin C and the gene expression of MMPs and TIMPs was determined by means of real‐time PCR.Results: The protein levels of MMP‐3, MMP‐7, MMP‐8, MMP‐9, TIMP‐1, TIMP‐2, periostin, and tenascin C were significantly higher in patients with CRSwNPs than in healthy control subjects. The adjusted logistic regression analyses showed that MMP‐3, MMP‐7, MMP‐8, MMP‐9, TIMP‐2, periostin, and tenascin C were related to the occurrence of CRSwNP. Spearman correlation test showed periostin was positively correlated with MMP‐3 and TIMP‐2, and tenascin C was positively correlated with MMP‐3, MMP‐7, MMP‐8, MMP‐9, and TIMP‐2. Periostin stimulated the gene expression of MMP‐3, MMP‐7, MMP‐8, and MMP‐9 in fibroblasts and MMP‐9 in epithelial cells ex vivo. Tenascin C stimulated the expression of MMP‐3, MMP‐7, MMP‐8, and MMP‐9 in epithelial cells. The expression of TIMPs in fibroblasts and epithelial cells was affected by neither periostin nor tenascin C.Conclusions: Periostin and tenascin C might be involved in the remodeling of nasal polyps by regulating the expression of different MMPs in epithelial cells and fibroblasts. Our findings have the potential to identify key factors of tissue remodeling in CRSwNPs.